Herpes simplex virus induces genital herpes, which is a sexually transmitted infection. Symptoms of genital herpes include blisters on or around the genitals, vaginal discharge, pelvic pain, and penile discharge. As per the WHO in December 2015, around 1 million sexually transmitted infections are acquired every day around the world. According to the WHO, around 15% of patients with herpes simplex virus infection in the United States have previously been diagnosed with genital herpes. In affluent nations, accurate diagnostic procedures such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, and real-time PCR assay are widely employed to diagnosis STIs. Moreover, these diagnostic procedures are highly expensive hence, this factor may hinder the growth of the market in the forecast period.
Valacyclovir is a type of antibiotic that is used to treat viral infections. Cold sores around the mouth (produced by herpes simplex) and chickenpox are treated with it in children (caused by varicella-zoster). It is used to treat shingles (herpes zoster) and cold sores around the mouth in adults. It’s an antiviral medication for influenza. It inhibits the spread of certain viruses. Famciclovir is a type of antiviral medication. Even across outbreaks, the viruses that cause these ailments live on in the body. Famvir is usually used as a one-time therapy to stop the spread of the infection or to keep the symptoms from becoming too bothersome. However, there is no exact cure to the infection but these antiviral drugs can help in reducing the symptoms.
In Europe, genital herpes treatment sales would grow at a CAGR of 3.4 %, owing to increased demand in the United Kingdom, Germany, and other countries. Further, high consumptions in the region are estimated to lead the growth of the market in the forecast period. Also growing Awareness and healthcare programs in the regions are further estimated to drive the growth of the regional market.
Despite a huge decline in the sales of Type of Drugs during the initial phase of pandemic spread and lockdown restrictions all over the region, the market is observed to pick up a quick pace for registering a CAGR of almost more than 4.3%, during the tenure of 2021 – 2027.
The report published by Maximize encompasses the market dynamics, which could affect the market growth of Genital Herpes Treatment in the region, the Value – Chain Analysis, and the PORTER’s analysis for the Genital Herpes Treatment market at a global level. The study is associated based on major segments and further into sub-segments, by Type of Drug (acyclovir, famciclovir, valacyclovir, and others) and Distribution Channel (hospitals, retail pharmacy, and online pharmacy) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2020, considering 2020 as the base year.
Lastly, the market research report provides a regional comparison and a complete country-level analysis for the latest trends, along with the major key players- GlaxoSmithKline, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Apotheca Inc., Sandoz Inc., Novartis AG, Hospira Inc., Novopharm Ltd., Dr. Reddy’s Laboratories Ltd., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd, Valeant Pharmaceuticals International Inc., Bausch Health Companies Inc., Cipla Inc., Eli Lilly, and Co., Gilead Sciences Inc
You can browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on the “Global Genital Herpes Treatment Market.”
https://www.maximizemarketresearch.com/market-report/global-genital-herpes-treatment-market/121336/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Office no. 4,
Navale IT Zone Phase-2,
Mumbai -Bangalore bypass highway,
Pune- 411041
Maharashtra, India
+91 9607195908